Clinical Trials Logo

Filter by:
NCT ID: NCT05845307 Not yet recruiting - Clinical trials for Squamous Cell Carcinoma of Head and Neck

Randomized Pre-surgical Window-of-Opportunity Trial of TTI-101 in Patients With Stage II-IV Resectable HPV-negative Squamous Cell Carcinoma of the Head and Neck

Start date: October 31, 2024
Phase: Early Phase 1
Study type: Interventional

To learn if TTI-101 can reduce the growth of HPV-negative squamous cell carcinomas of the head and neck when given before standard of care surgery.

NCT ID: NCT05844397 Not yet recruiting - Myopia Clinical Trials

SMILE vs. LASIK Using Contoura With Phorcides

Start date: May 15, 2023
Phase: N/A
Study type: Interventional

Subjects will undergo SMILE surgery in one eye and LASIK using Contoura with Phorcides on the contralateral eye to correct myopia.

NCT ID: NCT05844280 Not yet recruiting - Fracture of Foot Clinical Trials

The Role of Blood Flow Restriction Therapy in Postop Rehabilitation of Foot and Ankle Injuries

Start date: August 2026
Phase: N/A
Study type: Interventional

The purpose of the study is to determine the role of blood flow restriction (BFR) + neuromuscular electrical stimulation (NMES) in improving post-operative physical therapy and recovery after ankle fracture surgery. We expect to see improved muscle strength, less muscle wasting, and improved functional recovery after surgery when making these additions to routine post-operative (postop) physical therapy protocols.

NCT ID: NCT05843903 Not yet recruiting - Physical Activity Clinical Trials

Teen Mom 2: Improving Black Adolescent Maternal Cardiometabolic Health

Start date: May 1, 2024
Phase: N/A
Study type: Interventional

The proposed multicomponent digital health intervention has the potential to significantly impact the trajectory of maternal health in a rural, pregnant, Black adolescent population with the highest risks for cardiometabolic diseases worldwide. The proposed implementation strategy leverages mobile technologies which are ubiquitous across the socioeconomic gradient and proposes to train young adult WIC moms to deliver peer health coaching in a telehealth setting to address social barriers and support behavior change in pregnant, Black adolescent WIC clients in the Mississippi Delta - a rural region where the population is more than two-thirds percent Black and the teen birth rate is the highest in the United States. This is a scalable and sustainable approach to enhance WIC services and improve WIC's impact on population health and cardiometabolic health disparities in Black women.

NCT ID: NCT05843253 Not yet recruiting - Glioblastoma Clinical Trials

Study of Ribociclib and Everolimus in HGG and DIPG

Start date: June 28, 2024
Phase: Phase 2
Study type: Interventional

The goal of this study is to determine the efficacy of the study drugs ribociclib and everolimus to treat pediatric and young adult patients newly diagnosed with a high-grade glioma (HGG), including DIPG, that have genetic changes in pathways (cell cycle, PI3K/mTOR) that these drugs target. The main question the study aims to answer is whether the combination of ribociclib and everolimus can prolong the life of patients diagnosed with HGG, including DIPG.

NCT ID: NCT05842889 Not yet recruiting - Peer Support Clinical Trials

Adaptation and Implementation of Peer Support in Brazil

Start date: August 2024
Phase:
Study type: Observational

Mental disorders are among the leading causes of disability and morbidity worldwide, including Brazil, where despite having a comprehensive network of publicly-funded, free, community-based mental health treatment, it is estimated that only 26% of people with psychiatric conditions successfully connect to community-based care. The study team hypothesizes that the successful adaptation and implementation of an evidence-based model of peer support to Brazilian culture, will contribute to enhanced levels of engagement, improved continuity of care, and improvements in quality of life and wellbeing among persons living with SMI in Brazil. After this study, it will have established the feasibility, acceptability, safety and tolerability, of adapting a low-cost, culturally-responsive, evidence-based intervention to improve post-acute supports for people with SMI who access community mental health treatment.

NCT ID: NCT05842174 Not yet recruiting - Clinical trials for Hepatocellular Carcinoma

Targeting Ischemia-Induced Autophagy Dependence in Hepatocellular Carcinoma

TAQE
Start date: July 1, 2024
Phase: Phase 1/Phase 2
Study type: Interventional

Trans-arterial chemoembolization (TACE) is the most commonly used therapy for patients with unresectable hepatocellular carcinoma (HCC). TACE is a minimally invasive procedure that involves placing a catheter into the artery in the liver that feeds the tumor, administering chemotherapeutics and then blocking the artery with embolics in order to kill tumor cells by depriving them of essential oxygen and nutrients. While TACE has a proven survival benefit, local recurrence is common, and long-term survival rates are poor. Prior studies demonstrate that HCC cells survive the oxygen and nutrient deprivation through autophagy, a process of cellular self-eating, to provide nutrients required for survival. The proposed project will leverage this dependency to develop a novel approach to TACE that integrates autophagy inhibition to improve therapeutic response by increasing tumor cell killing and enhancing anti-tumor immunity.

NCT ID: NCT05841810 Not yet recruiting - COVID-19 Clinical Trials

Working Towards Empowered Community-driven Approaches to Increase Vaccination and Preventive Care Engagement

WEAVE
Start date: June 10, 2024
Phase: N/A
Study type: Interventional

This study will optimize, implement, and test the impact of our multicomponent health program that includes three primary implementation strategies (Cultural Weavers and co-creation, mHealth strategies using culturally meaningful text and voice messages, and care coordination). The investigators will use a participatory approach to engage community members in co-creating and optimizing our mHealth outreach and enhanced care coordination program components. The investigators will use a hybrid type 3 effectiveness-implementation sequential multiple assignment randomized trial (SMART) design to assess the impact of our multicomponent health program on implementation and outcome measures.

NCT ID: NCT05841784 Not yet recruiting - Clinical trials for Cardiovascular Diseases

HARP Mindfulness Study

Start date: March 15, 2024
Phase: N/A
Study type: Interventional

This study was designed using the Multiphase Optimization Strategy (MOST) framework to determine whether two supplemental components increase the efficacy of a mindfulness-based cognitive therapy program delivered via telephone (MBCT-T) for psychological distress. Specifically, this study will test mindfulness booster sessions to follow a standard 8-week MBCT-T intervention, as well as website support in patients with heart disease and/or heart disease risk factors.

NCT ID: NCT05839379 Not yet recruiting - Glioblastoma Clinical Trials

Targeted Pediatric High-Grade Glioma Therapy

Start date: June 28, 2024
Phase:
Study type: Observational

The goal of this study is to perform genetic sequencing on brain tumors from children, adolescents, and young adult patients who have been newly diagnosed with a high-grade glioma. This molecular profiling will decide if patients are eligible to participate in a subsequent treatment-based clinical trial based on the genetic alterations identified in their tumor.